Study at a glance
How was vitamin D tested in mice with disrupted sleep?
Researchers studied 24 male mice in four groups of six. Some mice had their usual rest period disturbed by a moving bar for ten hours a day over 28 days. The groups allowed comparisons with normal sleep, later recovery and vitamin D3 treatment. The researchers measured movement, stress hormones, immune cells and changes in the gut.
What changed in mice given vitamin D during sleep disruption?
The vitamin D group moved farther in one behaviour test. The proportions of some immune-cell types moved closer to those in mice with normal sleep. Two proteins involved in the barrier formed by the gut lining and propionate, a substance made by gut bacteria, were higher than with sleep disruption alone. Other results did not improve clearly, including several behaviour tests, clock-related genes and some immune measurements.
Did vitamin D restore sleep or all the affected systems?
The results suggest changes in selected measurements, not recovery of every system. The researchers did not measure sleep duration or brain activity during sleep. They therefore did not show that vitamin D restored sleep. More intestinal proteins do not by themselves prove that the gut barrier worked better. Changes in gut bacteria do not prove that those changes caused the hormone or behaviour results.
Do these mouse findings establish a treatment for sleep problems?
There were only six mice per group and many measurements. Some written claims in the paper disagreed with its graphs. The vitamin D treatment schedule was not clearly described, and starting blood vitamin D levels were not reported. The recovery group was assessed later than the other groups. This small animal experiment does not establish a treatment or a vitamin D dose for people with sleep problems.
Read the full article below ↓In a small mouse experiment, vitamin D3 accompanied changes in selected immune, gut and stress-related measurements after repeated mechanical sleep disruption. The results were mixed, and several broad claims in the paper’s discussion were not supported by the plotted treatment comparisons. The study did not establish that vitamin D restored sleep, normalised the whole stress axis or treated human sleep problems. For the shorter account, see Vitamin D3, Sleep Disruption and Stress-Immune-Gut Measurements: Study Summary.
This is a VD3FL analysis of the complete principal paper and all 11 main figures. The supplementary DOCX was not available for independent checking. The account uses verified main-paper results and identifies material disagreements between the prose and plots.
A model connecting sleep disturbance with several systems
Wu and colleagues investigated whether vitamin D3 could modify the consequences of repeated sleep disturbance in mice. They measured stress-hormone responses, behaviour, immune-cell proportions, microbial composition, intestinal proteins and microbial metabolites. The breadth makes the study relevant to both Vitamin D and Sleep: Wake Regulation and Vitamin D and Stress Physiology, while making it especially important to distinguish the results of each assay.
Twenty-four male C57BL/6J mice were divided into four groups of six: normal sleep, chronic sleep disruption, sleep disruption followed by recovery, and sleep disruption with vitamin D3. The study reports random group allocation and blinded behavioural and sample assessment. With six animals per group, however, individual observations can strongly influence the results.
What the disruption and treatment protocols establish
A horizontal bar moved through the cage once per minute from 8 am to 6 pm, ten hours daily for 28 days. The recovery group then had seven additional days before assessment. Consequently, recovery and the other conditions were not assessed at the same elapsed time. The recovery group is informative, but is not a perfectly simultaneous comparator for every endpoint.
The animals remained on a stable 12-hour light-dark schedule. This was mechanical disturbance during the usual rest period, not a rotating-light or human shift-work experiment. No EEG, total sleep duration or circadian phase was measured. The bar itself could affect movement and stress, so the model does not independently quantify how much of each downstream change was caused by lost sleep.
The paper gives a vitamin D3 amount of 1,000 IU/kg but does not clearly specify its administration route, frequency or starting schedule in the inspected methods. It would be unjustified to fill those gaps with a daily-gavage assumption. This animal protocol is not a human dose recommendation, and no human-equivalent calculation is warranted.
No baseline blood vitamin D assessment was reported. The experiment therefore does not show that a measured deficiency was corrected. These limits are central to any interpretation of treatment, rather than minor details that can be supplied from the paper’s title.
The stress-axis test needs the right comparison
The dexamethasone suppression test examines feedback in a stress-hormone system: a glucocorticoid signal is followed by a measurement of corticosterone, the principal measured hormone here. The general feedback framework is described in Vitamin D and the HPA Axis. The mice received saline on day 18 and dexamethasone on day 19, with blood sampled an hour later.
The plots show significant within-group suppression in normal-sleep and vitamin-D-treated mice, but not in the disrupted-sleep group. This does not by itself establish that treatment changed suppression significantly more than the comparison condition. A significant result in one group and a nonsignificant result in another are not a direct test of the difference between their responses.
The figure caption also names an unpaired, one-sided test despite the repeated-animal sequence described in the methods. The dexamethasone dose is not clearly supplied in the inspected method. End-of-experiment basal corticosterone did not show significant group differences. Taken together, these results do not justify describing the entire HPA axis as normalised.
Behaviour did not improve uniformly
Open-field movement distance was greater in the vitamin D group than in the disrupted-sleep group. Other behavioural results were less supportive. Nest scores carried the same significance letter across groups, so the plot did not demonstrate restored nesting. Centre-visiting time and elevated-plus-maze arm-entry preferences also did not show the broadly improved pattern implied by some narrative descriptions.
These tasks can reflect activity, motivation and responses to an unfamiliar environment. They are not direct diagnoses of depression, measures of human daytime functioning or comprehensive cognitive tests. The same distinction applies when connecting animal behaviour to the broader subject of Vitamin D and Brain. The study did not measure a clinical mood outcome.
The reported behavioural pattern is therefore selective: one movement measure changed favourably in the displayed treatment comparison, while several other measures did not. Preserving those nulls helps identify what further experiments would need to reproduce.
Hypothalamic genes were not a demonstrated clock rescue
The investigators measured selected transcripts in the hypothalamus. TNF-alpha, interleukin-6 and interferon-gamma did not show significant differences in the displayed comparisons. For the clock-related genes, vitamin D versus disrupted sleep did not significantly change Bmal1 or Clock; Cry1, Cry2 and Per2 were also null in the reported plots.
Recovery affected some comparisons, but a recovery-group difference is not evidence that the vitamin D intervention produced the same effect. A single endpoint transcript measurement is also different from observing an oscillation over time. The wider topic of Vitamin D and Circadian Biology requires distinctions among expression level, rhythmic amplitude, period and phase.
No receptor-deletion experiment established vitamin D receptor necessity, and no direct oxidative-stress measurement established the broader mechanism discussed in Vitamin D and Oxidative Stress. These remain possible neighbouring biological questions, not verified mediators of the particular treatment effects in this paper.
Immune-cell proportions changed selectively
Sleep disruption was accompanied by a higher neutrophil percentage and a lower lymphocyte percentage. The vitamin D comparison moved those proportions towards the normal-sleep group, and the basophil proportion was lower than in disrupted sleep. These measurements describe the composition of the sampled cells, not absolute counts of every cell type or a general test of immune competence.
The Th1-to-Th2 ratio was not restored in the displayed vitamin D comparison. Several T-cell outcomes were null, while recovery affected selected proportions. The natural-killer-cell chart used mean fluorescence intensity, a signal measurement, rather than a direct cell count.
This mixed pattern belongs within Vitamin D and Inflammatory Signalling, but cannot be condensed into universal anti-inflammatory rescue. A change in one cellular proportion can occur alongside no clear change in a cytokine transcript or another immune subset. The experiment supplies those separate observations, without proving a single mechanism connecting all of them.
Microbial composition and the diversity discrepancy
The researchers used bacterial 16S sequencing to describe the gut community. Relative abundances and community patterns differed among groups, with some vitamin D comparisons closer to normal-sleep profiles. Relative abundance is a proportion of a community; it does not independently establish absolute bacterial growth or a beneficial function.
The main prose says that alpha-diversity measures did not differ, but the Observed and Chao1 plots display some pairwise P values below .05. Shannon and Simpson measures were largely null. The report does not provide enough consistent analytic detail to reconcile that prose with every displayed comparison. A blanket statement that all diversity measures were unchanged would therefore be inaccurate.
The family labels also require care: the axes identify Muribaculaceae and Lachnospiraceae in the opposite order to a figure-caption description. This analysis follows the axes without treating the caption’s ordering as additional evidence. The commonly discussed Firmicutes-to-Bacteroidota ratio is not a universal clinical gut-health score.
These results connect with Vitamin D and Gut as measurements of community composition. They do not establish that changing the community caused the hormone or behavioural findings. No microbial-transfer or depletion experiment isolated such a causal route.
Predicted pathways are not measured metabolism
PICRUSt2 was used to infer potential microbial pathways from the sequencing data. Those predictions are not direct measurements of metabolic flux, host glycolysis or energy production in the brain. Their interpretation depends on the organisms represented and on the inference method.
In the displayed disruption-versus-normal comparisons, the pathway false-discovery-rate values were approximately .10-.20, rather than below .05. Some vitamin D-versus-disruption comparisons did meet the plotted threshold. These comparisons should remain separate: a significant treatment comparison does not retroactively make every initial disruption comparison significant.
Rounded displayed values of .00 are not literally zero probabilities. More generally, the many endocrine, behavioural, immune and microbial outcomes were not covered by one comprehensive multiplicity correction. Six mice per group and numerous one-sided comparisons make broad claims of restored systems particularly uncertain.
Intestinal proteins and short-chain fatty acids
In proximal-colon tissue, ZO-1 and claudin protein expression were higher with vitamin D than with sleep disruption alone. The occludin comparison was nonsignificant. Protein abundance can inform a barrier hypothesis, but it is not a direct measurement of intestinal permeability.
The LPS plot shows a lower value with vitamin D than with disrupted sleep, despite discussion language saying there were no significant LPS differences. The disruption-versus-normal comparison was itself nonsignificant. Reporting the actual treatment contrast is more accurate than adopting either a blanket normalisation claim or the blanket null statement.
Propionate was higher with vitamin D than with disruption alone. Butyrate was not significantly higher in that vitamin D comparison; recovery, rather than vitamin D, showed the significant increase. Acetate was null. The methods describe faecal short-chain-fatty-acid measurements, while the figure caption calls them serum measurements. This analysis follows the methods and preserves the sample-description discrepancy.
These findings do not establish whole-body Vitamin D and Homeostatic Balance or prove that the gut measurements mediated stress recovery. They identify particular tissue and metabolite observations that require replication and a more clearly specified treatment protocol.
Conclusion
The experiment reported selective changes in movement, immune proportions, intestinal proteins and propionate, with important nulls and several prose-versus-plot conflicts. It did not demonstrate restored sleep, universal immune recovery, clock normalisation or a causal gut-to-brain mechanism. Its value is an exploratory set of measurements in a small animal model, not a clinical supplementation result.
The authors reported Taiwanese research and institutional support and declared no conflicts of interest. The unavailable supplement limits independent checking of additional body-weight and intake observations; those are not used here to resolve the causal questions.
Scientific sources
Wu CW, Huang YJ, Xu JW, et al. Vitamin D3 Improves Hypothalamic-Pituitary-Adrenal Axis Function, Immunological Responses, and Gut Dysbiosis in Sleep Desynchrony. Brain and Behavior. 2025;15(11):e71084. DOI 10.1002/brb3.71084; PMID 41273001. Readable full text is available at PubMed Central.
Related reading
A cross-sectional study observing the association of psychosocial stress and dietary intake with gut microbiota genera and alpha diversity among a young adult cohort of black and white women in Birmingham, Alabama
The primary aim of this study was to examine the associations of psychosocial stress measures and dietary variables with gut microbiota genera abundance and alpha diversity among young adult, black and white females.
Original paper ↗Read more →Mediterranean Diet and Olive Oil Redox Interactions on Lactate Dehydrogenase Mediated by Gut Oscillibacter in Patients with Long-COVID-19 Syndrome
Participants were classified into low (n = 54) and high (n = 134) MD adherence groups (cut-off of 7 points based on previous studies utilizing the same threshold in the assessment of MD adherence).
Original paper ↗Read more →Vitamin D Deficiency in the Gulf Cooperation Council: Exploring the Triad of Genetic Predisposition, the Gut Microbiome and the Immune System
In this review, we aim to expand our understanding of the causes of Vitamin D deficiency in the GCC countries and explore the potential relationship between the genetic predisposition, Vitamin D levels, immune system and the gut microbiome composition.
Original paper ↗Read more →Vitamin D, Gut Microbiota, and Cancer Immunotherapy: A Potentially Effective Crosstalk
Recent breakthroughs in cancer immunotherapy have shown remarkable success, yet treatment efficacy varies significantly among individuals.
Original paper ↗Read more →Vitamin D3 Improves Hypothalamic-Pituitary-Adrenal Axis Function, Immunological Responses, and Gut Dysbiosis in Sleep Desynchrony
Chronic sleep desynchrony proliferates in modern society, characterized by extended wakefulness and disrupted circadian rhythms over a long period, and is associated with various physiological and immune dysfunctions.
Original paper ↗Read more →Vitamin D3, Sleep Disruption and Stress-Immune-Gut Measurements: Study Summary
A concise review of a 24-mouse experiment on vitamin D3 during sleep disruption, separating measured stress, immune and gut results from broader claims.
Read more →A journal post follows vitamin D’s relationship with gut bacteria in IBD
Cell Reports Medicine introduced research combining blood and stool measurements in people with inflammatory bowel disease.
Read more →Serum Vitamin D3 Concentration, Sleep, and Cognitive Impairment among Older Adults in China
Background: Cognitive decline in older adults has become one of the critical challenges to global health.
Original paper ↗Read more →Sleep-Disordered Breathing in Hospitalized Geriatric Patients with Mild Dementia and Its Association with Cognition, Emotion and Mobility
The tolerant group exhibited more symptoms of depression and higher physical fitness compared to the non-tolerant group.
Original paper ↗Read more →Dietary Magnesium Intake Is Associated With Self‐Reported Short Sleep Duration but Not Self‐Reported Sleep Disorder
The study dataset includes participants from five cycles (2009 to 2018) of NHANES.
Original paper ↗Read more →Role of Increasing Body Mass Index in Gut Barrier Dysfunction, Systemic Inflammation, and Metabolic Dysregulation in Obesity
Results: The statistical analyses of the clinical parameters were based on the full sample set, whereas a subset composed of 37 randomized patients was inspected for the GC/MS metabolite profiling of fecal specimens.
Original paper ↗Read more →The mediating role of sleep quality in the association between inflammatory disease activity and health-related quality of life in rheumatoid arthritis
This study aimed to investigate the interplay between inflammatory/metabolic markers and sleep quality, and to determine whether sleep quality mediates the relationship between disease activity by DAS28-ESR and health-related quality of life.
Original paper ↗Read more →Vitamin D receptor regulates intestinal proteins involved in cell proliferation, migration and stress response
In contrast, proteins that are involved in transport of bile and fatty acids were down-regulated in small intestine of mice lacking VDR compared to WT mice.
Original paper ↗Read more →Researchers follow vitamin D and gut inflammation over 12 weeks
Medical News Today reported on changes in symptoms and immune markers among 48 adults with inflammatory bowel disease.
Read more →Levodopa-Carbidopa-Entacapone Intestinal Gel for Advanced Parkinson’s Disease: Results from a Monocentric Study Evaluating Both Motor and Non-Motor Manifestations
Parkinson’s disease (PD) in advanced stages becomes, over time, a significant challenge, as oral medication becomes ineffective, and it may become necessary to switch to device-assisted therapy (DAT).
Original paper ↗Read more →Mechanisms and disease associations of oxidative stress-mediated brain-bone axis dysregulation: a knowledge mapping and trend analysis based on Bibliometrics
Oxidative stress, characterized by the systemic imbalance between reactive oxygen species and antioxidant defenses, is increasingly recognized as a central pathological nexus driving the dysregulation of the brain-bone axis.
Original paper ↗Read more →Nutritional modulation of neuroinflammation in Alzheimer’s disease and mild cognitive impairment: a systematic review of clinical and preclinical evidence
This systematic review evaluated the clinical and preclinical evidence regarding the effects of nutritional interventions on neuroinflammatory mechanisms relevant to AD and MCI.
Original paper ↗Read more →Research trend and hotspots of polycystic ovary syndrome with depression from 1993 to 2024: a bibliometric analysis
Polycystic ovary syndrome (PCOS), a common endocrine disorder, affects women of reproductive age, and its adverse consequences affect women throughout their lifespan, from adolescence to postmenopause.
Original paper ↗Read more →Sex differences in clinical risk factors for Alzheimer's dementia patients with early-onset and late-onset
The objective of this study is to identify the risk factors that contribute to sex differences in patients with Alzheimer dementia (AD), specifically focusing on Early-Onset Alzheimer’s Dementia (EAOD) and Late-Onset Alzheimer Dementia (LOAD).
Original paper ↗Read more →Vitamin D, systemic inflammation, and motoric cognitive risk: exploring the risk factors and mediation pathways
Motoric cognitive risk (MCR) syndrome, defined by subjective cognitive complaints and slow gait, is a predementia condition associated with multiple adverse outcomes.
Original paper ↗Read more →Vitamin D and Gut
Explore how vitamin D relates to gut regulation through barrier integrity, immune signalling, and whole-body physiological coordination.
Read more →Original sources
Vitamin D3 Improves Hypothalamic-Pituitary-Adrenal Axis Function, Immunological Responses, and Gut Dysbiosis in Sleep Desynchrony
Chronic sleep desynchrony proliferates in modern society, characterized by extended wakefulness and disrupted circadian rhythms over a long period, and is associated with various physiological and immune dysfunctions.
Publication details
Wu CW, Huang YJ, Xu JW, et al. Vitamin D3 Improves Hypothalamic-Pituitary-Adrenal Axis Function, Immunological Responses, and Gut Dysbiosis in Sleep Desynchrony. Brain and Behavior. 2025;15(11):e71084. DOI 10.1002/brb3.71084; PMID 41273001. Readable full text is available at PubMed Central.